PHRX OTC
Pharmagen, Inc.
1W: +900.0%
1M: +900.0%
3M: +900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -98.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$5K
+0.0% ▲
Gross Profit
$3K
+0.0% ▲
Operating Income
-$2K
+0.0% ▲
Net Income
-$6K
+0.0% ▲
EPS (Diluted)
$-0.02
+0.0% ▲
EBITDA
-$3M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 |
|---|---|
| Revenue | $5K |
| YoY Growth | +0.0% |
| Cost of Revenue | $2K |
| Gross Profit | $3K |
| Gross Margin | 63.3% |
| R&D Expenses | $0 |
| SG&A Expenses | $5K |
| Operating Expenses | $6K |
| Operating Income | -$2K |
| Operating Margin | -44.9% |
| Interest Expense | $3M |
| Income Before Tax | -$6K |
| Tax Expense | $457 |
| Net Income | -$6K |
| Net Margin | -134.2% |
| EPS (Diluted) | $-0.02 |
| EBITDA | -$3M |
| Shares Outstanding | 383500 |